Search Login Register

Prosopagnosia Summary

Description: The inability to recognize a familiar face or to learn to recognize new faces. This visual agnosia is most often associated with lesions involving the junctional regions between the temporal and occipital lobes. The majority of cases are associated with bilateral lesions, however unilateral damage to the right occipito-temporal cortex has also been associated with this condition. (From Cortex 1995 Jun;31(2):317-29)

Also Known As: Prosopagnosia, Acquired; Prosopagnosia, Developmental; Acquired Prosopagnosia; Acquired Prosopagnosias; Agnosia for Face Show All >>

Networked: 27 relevant articles (0 outcomes, 2 trials/studies) for this Disease

Key Drugs and Agents for Prosopagnosia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Oxygen : 2 studies in 2 results : IBA
  2. hereditary Prosopagnosia : 10 results : IBA
  3. Carbon Monoxide : 3 results : IBA
  4. Oxytocin (Pitocin) : 2 results : FDA 7 Generic
  5. Protein Isoforms (Isoforms) : 1 result : IBA
  6. N-Methylaspartate (NMDA) : 1 result : IBA
  7. Sodium Glutamate (Accent) : 1 result : IBA
  8. Mescaline (Peyote) : 1 result : IBA
  9. Galactose (Galactopyranose) : 1 result : FDA 3 Generic
  10. Antibodies : 1 result : IBA
Show All >>

Diseases Related to Prosopagnosia

  1. Color Vision Defects (Color Blindness)
  2. Prosopagnosia
  3. Frontotemporal Lobar Degeneration (Semantic Dementia)
  4. Stroke (Strokes)
  5. Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
Show All >>

Key Therapies for Prosopagnosia

Efficacy Chart >>
  1. Lipreading (Lip Reading) : 1 result
  2. Immunotherapy : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.